Dr. Sharman's CLL & Lymphoma Blog

Translating basic science and clinical breakthroughs into language we all can understand

Pages

▼
Sunday, November 8, 2015

FCR: The Empire Strikes Back

›
I'm not really a huge Star Wars guy, but the title seemed appropriate for the content.  For web savvy CLL patients FCR is a lot like the...
32 comments:
Thursday, June 4, 2015

Frontline Survival Benefit for Ibrutinib

›
NEWSFLASH: Resonate-2, the randomized phase III study comparing frontline ibrutinib against chlorambucil met its primary endpoint of progr...
7 comments:
Sunday, May 17, 2015

Take your pills - ibrutinib dosing matters!

›
When we are investigating new drugs that have never been tested before, we start with what's called a phase 1 study.  Historically, the ...
13 comments:
‹
›
Home
View web version
Powered by Blogger.